TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.

Abstract:

:Protein S is a cofactor for tissue factor pathway inhibitor (TFPI), accelerating the inhibition of activated factor X (FXa). TFPI Kunitz domain 3 residue Glu226 is essential for enhancement of TFPI by protein S. To investigate the complementary functional interaction site on protein S, we screened 44 protein S point, composite or domain swap variants spanning the whole protein S molecule for their TFPI cofactor function using a thrombin generation assay. Of these variants, two protein S/growth arrest-specific 6 chimeras, with either the whole sex hormone-binding globulin (SHBG)-like domain (Val243-Ser635; chimera III) or the SHBG laminin G-type 1 subunit (Ser283-Val459; chimera I), respectively, substituted by the corresponding domain in growth arrest-specific 6, were unable to enhance TFPI. The importance of the protein S SHBG-like domain (and its laminin G-type 1 subunit) for binding and enhancement of TFPI was confirmed in FXa inhibition assays and using surface plasmon resonance. In addition, protein S bound to C4b binding protein showed greatly reduced enhancement of TFPI-mediated inhibition of FXa compared with free protein S. We show that binding of TFPI to the protein S SHBG-like domain enables TFPI to interact optimally with FXa on a phospholipid membrane.

journal_name

Blood

journal_title

Blood

authors

Reglińska-Matveyev N,Andersson HM,Rezende SM,Dahlbäck B,Crawley JT,Lane DA,Ahnström J

doi

10.1182/blood-2014-01-551812

subject

Has Abstract

pub_date

2014-06-19 00:00:00

pages

3979-87

issue

25

eissn

0006-4971

issn

1528-0020

pii

blood-2014-01-551812

journal_volume

123

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Role of the sialophorin (CD43) receptor in mediating influenza A virus-induced polymorphonuclear leukocyte dysfunction.

    abstract::Polymorphonuclear leukocytes (PMNLs) exposed to influenza A virus (IAV) undergo activation of the respiratory burst followed by depression of cell function when subsequently exposed to particulate or soluble stimuli. The effect of IAV on PMNLs is likely to be mediated through the attachment of IAV to one or more speci...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Abramson JS,Hudnor HR

    更新日期:1995-03-15 00:00:00

  • E-selectin mediates leukocyte rolling in interleukin-1-treated rabbit mesentery venules.

    abstract::The selectins are lectin-like cell surface glycoproteins that have been implicated in playing a crucial role in the initiation of leukocyte adhesion to endothelial cells (ECs) during inflammation. Binding of selectins under conditions of flow mediates leukocyte rolling, which in vivo is almost exclusively observed in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Olofsson AM,Arfors KE,Ramezani L,Wolitzky BA,Butcher EC,von Andrian UH

    更新日期:1994-10-15 00:00:00

  • T cell receptor (alpha, beta, gamma) gene rearrangements and expression in normal and leukemic large granular lymphocytes/natural killer cells.

    abstract::The large granular lymphocyte (LGL) population, which effects a natural killer (NK) function, consists of cells whose lineage derivation has not been clearly established on the basis of phenotypic and functional properties. To clarify the relationship of LGL/NK cells to T cells we studied patterns of rearrangement and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pelicci PG,Allavena P,Subar M,Rambaldi A,Pirelli A,Di Bello M,Barbui T,Knowles DM 2nd,Dalla-Favera R,Mantovani A

    更新日期:1987-11-01 00:00:00

  • The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells.

    abstract::The association of fibroblast growth factor receptor 3 (FGFR3) expression with t(4;14) multiple myeloma (MM) and the demonstration of the transforming potential of this receptor tyrosine kinase (RTK) make it a particularly attractive target for drug development. We report here a novel and highly specific anti-FGFR3-ne...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4179

    authors: Trudel S,Stewart AK,Rom E,Wei E,Li ZH,Kotzer S,Chumakov I,Singer Y,Chang H,Liang SB,Yayon A

    更新日期:2006-05-15 00:00:00

  • Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.

    abstract::Intravascular hemolysis describes the relocalization of heme and hemoglobin (Hb) from erythrocytes to plasma. We investigated the concept that erythrocyte membrane microparticles (MPs) concentrate cell-free heme in human hemolytic diseases, and that heme-laden MPs have a physiopathological impact. Up to one-third of c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-589283

    authors: Camus SM,De Moraes JA,Bonnin P,Abbyad P,Le Jeune S,Lionnet F,Loufrani L,Grimaud L,Lambry JC,Charue D,Kiger L,Renard JM,Larroque C,Le Clésiau H,Tedgui A,Bruneval P,Barja-Fidalgo C,Alexandrou A,Tharaux PL,Boulanger CM

    更新日期:2015-06-11 00:00:00

  • The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium.

    abstract::The CC chemokine receptor 8 (CCR8) is expressed on monocytes and type 2 T lymphocytes. CCR8 is the sole receptor for the human CC chemokine I-309, as well as for viral monocyte inflammatory protein-I (vMIP-I), a human chemokine homologue induced in human cells by the Kaposi sarcoma-related human herpesvirus-8. Recentl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.1.39

    authors: Haque NS,Fallon JT,Taubman MB,Harpel PC

    更新日期:2001-01-01 00:00:00

  • Downstream effectors of oncogenic ras in multiple myeloma cells.

    abstract::Ectopic expression of mutated K-ras or N-ras in the interleukin 6 (IL-6)-dependent ANBL6 multiple myeloma cell line induces cytokine-independent growth. To investigate the signaling pathways activated by oncogenic ras that may stimulate IL-6-independent growth, we compared ANBL6 cells stably transfected with mutated K...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-08-2640

    authors: Hu L,Shi Y,Hsu JH,Gera J,Van Ness B,Lichtenstein A

    更新日期:2003-04-15 00:00:00

  • Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.

    abstract::Cutaneous T-cell lymphoma (CTCL) constitutes a malignant proliferative disease involving mostly CD4(+) T cells arising in the skin. Because of the lack of curative treatment options, interferons (IFN) have been introduced into the therapy of CTCL. Although effective even in advanced disease, response rates were about ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Stadler R,Otte HG,Luger T,Henz BM,Kühl P,Zwingers T,Sterry W

    更新日期:1998-11-15 00:00:00

  • Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.

    abstract::Uncontrolled activation of the complement system against endothelial and blood cells is central to the pathogenesis of atypical hemolytic uremic syndrome (aHUS). aHUS patients frequently carry mutations in the inhibitory complement regulator factor H (FH). Mutations cluster in domains 19 and 20 (FH19-20), which are cr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-11-680009

    authors: Hyvärinen S,Meri S,Jokiranta TS

    更新日期:2016-06-02 00:00:00

  • Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma.

    abstract::We developed a clinical prediction rule for bone marrow involvement (BMI) in Hodgkin lymphoma based on 826 patients and validated it in 654 additional patients. Independent prognostic factors for BMI were x1, B symptoms; x2, stage III/IV prior to bone marrow biopsy; x3, anemia; x4, leukocytes fewer than 6 x 10(9)/L; x...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-01-0379

    authors: Vassilakopoulos TP,Angelopoulou MK,Constantinou N,Karmiris T,Repoussis P,Roussou P,Siakantaris MP,Korkolopoulou P,Kyrtsonis MC,Kokoris SI,Dimopoulou MN,Variamis E,Viniou NA,Konstantopoulos K,Dimitriadou EM,Androulaki A,Pa

    更新日期:2005-03-01 00:00:00

  • Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.

    abstract::Using data from ARISTOTLE, we describe the periprocedural management of anticoagulation and rates of subsequent clinical outcomes among patients chronically anticoagulated with warfarin or apixaban. We recorded whether (and for how long) anticoagulant therapy was interrupted preprocedure, whether bridging therapy was ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2014-08-595496

    authors: Garcia D,Alexander JH,Wallentin L,Wojdyla DM,Thomas L,Hanna M,Al-Khatib SM,Dorian P,Ansell J,Commerford P,Flaker G,Lanas F,Vinereanu D,Xavier D,Hylek EM,Held C,Verheugt FW,Granger CB,Lopes RD

    更新日期:2014-12-11 00:00:00

  • Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice.

    abstract::Targeting cancer stem cells is of paramount importance in successfully preventing cancer relapse. Recently, in silico screening of public gene-expression datasets identified cyclooxygenase-derived cyclopentenone prostaglandins (CyPGs) as likely agents to target malignant stem cells. We show here that Δ(12)-PGJ(3), a n...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-11-317750

    authors: Hegde S,Kaushal N,Ravindra KC,Chiaro C,Hafer KT,Gandhi UH,Thompson JT,van den Heuvel JP,Kennett MJ,Hankey P,Paulson RF,Prabhu KS

    更新日期:2011-12-22 00:00:00

  • Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

    abstract::We report 2 novel, cryptic chromosomal abnormalities in precursor B-cell acute lymphoblastic leukemia (BCP-ALL): a translocation, either t(X;14)(p22;q32) or t(Y;14)(p11;q32), in 33 patients and an interstitial deletion, either del(X)(p22.33p22.33) or del(Y)(p11.32p11.32), in 64 patients, involving the pseudoautosomal ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-208397

    authors: Russell LJ,Capasso M,Vater I,Akasaka T,Bernard OA,Calasanz MJ,Chandrasekaran T,Chapiro E,Gesk S,Griffiths M,Guttery DS,Haferlach C,Harder L,Heidenreich O,Irving J,Kearney L,Nguyen-Khac F,Machado L,Minto L,Majid A,

    更新日期:2009-09-24 00:00:00

  • Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases.

    abstract::The signals that mediate T-cell infiltration during T-cell autoimmune diseases are poorly understood. The chemokine CCL21 (originally isolated by us and others as Exodus-2/6Ckine/SLC/TCA4) is highly potent and highly specific for stimulating T-cell migration. However, it is thought to be expressed only in secondary ly...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-05-1586

    authors: Christopherson KW 2nd,Hood AF,Travers JB,Ramsey H,Hromas RA

    更新日期:2003-02-01 00:00:00

  • Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease.

    abstract::Sickle cell disease (SCD) is characterized by recurring episodes of vascular occlusion in which neutrophil activation plays a major role. The disease is associated with chronic hemolysis with elevated cell-free hemoglobin and heme. The ensuing depletion of heme scavenger proteins leads to nonspecific heme uptake and h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-10-529982

    authors: Chen G,Zhang D,Fuchs TA,Manwani D,Wagner DD,Frenette PS

    更新日期:2014-06-12 00:00:00

  • Acceleration of mesoderm development and expansion of hematopoietic progenitors in differentiating ES cells by the mouse Mix-like homeodomain transcription factor.

    abstract::The cellular and molecular events underlying the formation and differentiation of mesoderm to derivatives such as blood are critical to our understanding of the development and function of many tissues and organ systems. How different mesodermal populations are set aside to form specific lineages is not well understoo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4120

    authors: Willey S,Ayuso-Sacido A,Zhang H,Fraser ST,Sahr KE,Adlam MJ,Kyba M,Daley GQ,Keller G,Baron MH

    更新日期:2006-04-15 00:00:00

  • Follicular helper T-cell-related lymphomas.

    abstract::In this issue of Blood, Wang et al describe the occurrence and pathogenetic relevance of IDH2R172 mutations in angioimmunoblastic T-cell lymphoma (AITL). ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-08-665075

    authors: Pileri SA

    更新日期:2015-10-08 00:00:00

  • Antisickling effect of tellurite: a potent membrane-acting agent in vitro.

    abstract::Potassium tellurite (K2TeO3) was found to be a potent antisickling agent that inhibited red cell sickling at concentrations less than 10 mumol/L. The inhibitory effect depended on the incubation time, with the effect increasing with longer incubation periods. Because tellurite causes swelling of red cells, and because...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Asakura T,Shibutani Y,Reilly MP,DeMeio RH

    更新日期:1984-07-01 00:00:00

  • Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection.

    abstract::A recent clinical trial for adrenoleukodystrophy (ALD) showed the efficacy and safety of lentiviral vector (LV) gene transfer in hematopoietic stem progenitor cells. However, several common insertion sites (CIS) were found in patients' cells, suggesting that LV integrations conferred a selective advantage. We performe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-306761

    authors: Biffi A,Bartolomae CC,Cesana D,Cartier N,Aubourg P,Ranzani M,Cesani M,Benedicenti F,Plati T,Rubagotti E,Merella S,Capotondo A,Sgualdino J,Zanetti G,von Kalle C,Schmidt M,Naldini L,Montini E

    更新日期:2011-05-19 00:00:00

  • Loxoribine induces chronic lymphocytic leukemia B cells to traverse the cell cycle.

    abstract::Leukemic B cells from a majority of patients with chronic lymphocytic leukemia (CLL) enter the cell cycle upon stimulation in vitro with loxoribine, a potent 7,8-disubstituted guanine ribonucleoside immunostimulant. In the absence of added costimulants, a proportion of these cells become activated and undergo DNA synt...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Goodman MG,Wormsley SB,Spinosa JC,Piro LD

    更新日期:1994-11-15 00:00:00

  • Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia B.

    abstract::Development of inhibitory antibodies is a serious complication of treatment with repeated factor IX infusions in a minority of patients with hemophilia B. Such antibodies detected in 8 patients have been characterized. Typing studies revealed that patients' immune response toward factor IX is highly heterogeneous and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.5.1416

    authors: Christophe OD,Lenting PJ,Cherel G,Boon-Spijker M,Lavergne JM,Boertjes R,Briquel ME,de Goede-Bolder A,Goudemand J,Gaillard S,d'Oiron R,Meyer D,Mertens K

    更新日期:2001-09-01 00:00:00

  • Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo.

    abstract::Subsets of natural killer (NK) cells are characterized by the expression of inhibitory and/or stimulatory receptors specific for major histocompatibility complex (MHC) class I determinants. In mice, these include the Ly49 family of molecules. One mechanism by which tumor cells may evade NK cell killing is by expressin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.10.3132

    authors: Koh CY,Blazar BR,George T,Welniak LA,Capitini CM,Raziuddin A,Murphy WJ,Bennett M

    更新日期:2001-05-15 00:00:00

  • Monoclonal Lym-1 antibody-dependent lysis of B-lymphoblastoid tumor targets by human complement and cytokinine-exposed mononuclear and neutrophilic polymorphonuclear leukocytes.

    abstract::Lym-1 is a murine IgG2a monoclonal antibody that recognizes a polymorphic variant of HLA-DR antigens on malignant B cells, with minimal cross-reactivity with normal tissues. Because it can be safely administered in vivo, a detailed knowledge of its ability to recruit and trigger the antitumor immune effector systems i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ottonello L,Morone P,Dapino P,Dallegri F

    更新日期:1996-06-15 00:00:00

  • Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states.

    abstract::Apoptotic cells were shown to induce dendritic cell immune tolerance. We applied a proteomic approach to identify molecules that are secreted from apoptotic monocytes, and thus may mediate engulfment and immune suppression. Supernatants of monocytes undergoing apoptosis were collected and compared using sodium dodecyl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-03-013334

    authors: Krispin A,Bledi Y,Atallah M,Trahtemberg U,Verbovetski I,Nahari E,Zelig O,Linial M,Mevorach D

    更新日期:2006-11-15 00:00:00

  • Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family.

    abstract::The study of the molecular bases of thrombophilia in a large family with 4 symptomatic members is reported. Three thrombophilic genetic components (FV R506Q, FV H1299R, and PT 20210G/A), all affecting the activity of the prothrombinase complex, were detected alone and in combination in various family members. In addit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Castoldi E,Simioni P,Kalafatis M,Lunghi B,Tormene D,Girelli D,Girolami A,Bernardi F

    更新日期:2000-08-15 00:00:00

  • Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression.

    abstract::CD56(high) acute myeloid leukemias (AMLs) have a poor prognosis, but it has been unclear how CD56 expression is controlled and how it relates to clinical aggressiveness. We show that CD56 expression on AML cells correlates with an abnormal expression pattern of runt-related transcription factor 1 (RUNX1) isoforms. Whe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-02-074203

    authors: Gattenloehner S,Chuvpilo S,Langebrake C,Reinhardt D,Müller-Hermelink HK,Serfling E,Vincent A,Marx A

    更新日期:2007-09-15 00:00:00

  • Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study.

    abstract::Six hundred twelve eligible, previously untreated patients with active multiple myeloma and at least some data available for analysis were entered into a randomized trial (Southwest Oncology Group [SWOG] Phase III myeloma study 8229/30), in which the prognostic significance of pretreatment serum beta 2 microglobulin l...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Durie BG,Stock-Novack D,Salmon SE,Finley P,Beckord J,Crowley J,Coltman CA

    更新日期:1990-02-15 00:00:00

  • Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome.

    abstract::We examined the prevalence and prognostic relevance of bone marrow reticulin fibrosis in 526 patients with World Health Organization-defined polycythemia vera evaluated at the time of initial diagnosis. Seventy-four patients (14%) displayed mostly grade 1 reticulin fibrosis, with only 2 cases showing higher-grade fibr...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2011-11-393819

    authors: Barbui T,Thiele J,Passamonti F,Rumi E,Boveri E,Randi ML,Bertozzi I,Marino F,Vannucchi AM,Pieri L,Rotunno G,Gisslinger H,Gisslinger B,Müllauer L,Finazzi G,Carobbio A,Gianatti A,Ruggeri M,Nichele I,D'Amore E,Rambald

    更新日期:2012-03-08 00:00:00

  • The proportion of mitoses in different cell lineages changes during short-term culture of normal human bone marrow.

    abstract::To determine the hematopoietic cell lineage of mitotic cells in human bone marrow on direct examination and after 24-hour culture, marrow mitoses from four healthy individuals were studied, using a new technique that allows analysis of karyotypes in cells whose cell membrane and cytoplasm have been preserved. Mitoses ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Keinänen M,Knuutila S,Bloomfield CD,Elonen E,de la Chapelle A

    更新日期:1986-05-01 00:00:00

  • Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro.

    abstract::Bryostatin 1, a macrocyclic lactone isolated from the marine bryozoan Bugula neritina, has demonstrated both antineoplastic activity against the murine P388 leukemia line in vivo and stimulatory activity against mouse and human hematopoietic progenitors. We studied the effects of bryostatin 1 on the growth of human le...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jones RJ,Sharkis SJ,Miller CB,Rowinsky EK,Burke PJ,May WS

    更新日期:1990-03-15 00:00:00